ExploreWatchlistsPricing
  1. US-listed companies
  2. Edesa Biotech, Inc.
  3. Financials
  4. Research & development

Edesa Biotech, Inc. (EDSA)

Market cap
$93.25M
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Sep 30, 20254+27.30%
Sep 30, 20243-39.89%
Sep 30, 20235-64.05%
Sep 30, 202213-25.70%
Sep 30, 202118+439.04%
Sep 30, 20203+59.50%
Sep 30, 20182+5.78%
Sep 30, 20172+14.11%
Sep 30, 20162+67.99%
Sep 30, 20151

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat